Most Recent
Allergan appeals loss in Botox trade mark dispute
Botox maker Allergan has appealed a court judgment tossing most of trade mark case against an Australian cosmetics company that sells topical creams as Botox alternatives.
Settlement reached in Illinois Tool Works lawsuit over concrete patent
An Australian concrete product maker has settled a lawsuit brought by US industrial equipment manufacturer Illinois Tool Works over its patents for precast concrete products.
Judge frowns on Allergan’s ‘Botox’ trade mark lawsuit
Botox maker Allergan has lost a lawsuit that accused an Australian cosmetics company that sells topical creams as an alternative to Botox injections of infringing its Botox trade mark.
US industrial giant Illinois Tool Works sues Aussie concrete company for patent infringement
US industrial equipment manufacturer Illinois Tool Works has launched Federal Court patent infringement proceedings against an Australian producer of precast concrete products.
Bayer’s parasite treatment patent bites the dust after challenge by Abbey
Animal health company Abbey Laboratories has successfully challenged an application by rival Bayer Australia for a patent covering a treatment for biting lice.
Bayer loses opposition to ‘Preceed’ weed killer trade mark
Agricultural giant Bayer can't block an Australian herbicide maker from trade marking 'Preceed' for its products, with a delegate from the Trade Marks Office finding the mark was not deceptively similar to Bayer's 'Precept' weed killer mark.
Judge tosses Vagisil maker’s challenge to European rival’s trade mark
The international company behind the Vagisil feminine hygiene brand has lost its bid to stop a European competitor from registering Vagisan as a trade mark in Australia.
160-year-old IP boutique Watermark to hang up its hat
IP boutique Griffith Hack will soon have around 80 practicing lawyers when it absorbs Australia's oldest specialist intellectual property firm Watermark next year.
Kymab to attack Regeneron’s mice experiments in human rat patent case
UK biopharmaceutical company Kymab may attack experiments done by US biotechnology giant Regeneron creating genetically modified mice with splices of human genomes, as it defends its proposed patent for a human rat.
Delegate denies opposition to Kraft changes to heat-resistant chocolate patent
Kraft Foods can amend its patent application for a chocolate that doesn't melt in the summer months, after a delegate found many of the claims of the patent lacked clarity and support.